{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-25-000035","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.482448+00:00","generated_at":"2026-05-21T00:52:28.053997+00:00","sec_items":["1.01","2.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Merit Medical acquires Biolife for $120M in cash; adds StatSeal/WoundSeal hemostasis products","bullets":["Purchase price $120M cash; Biolife becomes wholly-owned subsidiary of Merit.","Biolife's revenue projected at ~$18M annualized starting FY 2026 with mid-teens growth.","StatSeal/WoundSeal products address ~$350M global hemostasis market.","Merit reaffirms FY 2025 guidance; acquisition slightly dilutive to 2025 non-GAAP profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-25-000035","json":"https://secwatch.observer/filing/0000856982-25-000035.json","markdown":"https://secwatch.observer/filing/0000856982-25-000035.md","text":"https://secwatch.observer/filing/0000856982-25-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698225000035/0000856982-25-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698225000035/mmsi-20250516x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T00:52:28.053997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}